ConductScience.org, home

Drug · CHEMBL983

SUCCINYLCHOLINE CHLORIDE

7 sourcespipelines-2026-09-18-0.3.1

Download JSON
Cite this record

ConductScience Library. SUCCINYLCHOLINE CHLORIDE. Drugs and targets, record CHEMBL983. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL983

On this page

Drug

Names and IDs as ChEMBL gives them, through Open Targets.

Name
SUCCINYLCHOLINE CHLORIDE
ChEMBL
ChEMBL ID
CHEMBL983
ChEMBL
Type
Small molecule
ChEMBL
Brand names
Anectine, Quelicin, Quelicin preservative free, Scoline, Sucostrin
ChEMBL
Other names
Chlorure de suxamethonium, Choline chloride succinate (2:1), Cloruro de suxametonio, NSC-49132, Suxamethone, Suxamethonii chloridum, Suxamethonium chloride, Suxamethonium chloride dihydrate, Suxamethonium chloride hydrate
ChEMBL
Parent form
SUXAMETHONIUM, CHEMBL703
Drugs and targets
InChIKey
YOEWQQVKRJEPAE-UHFFFAOYSA-L
ChEMBL
Open Targets' highest stage
Approval, as Open Targets' drug record gives it
Open Targets

Targets5

The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.

TargetProteinMechanismActionGene in Genes
CHRNA1Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonistAGONISThttps://conductscience.org/library/genes/1134
CHRNB1Muscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonistAGONISThttps://conductscience.org/library/genes/1140
CHRNDMuscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonistAGONISThttps://conductscience.org/library/genes/1144
CHRNEMuscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonistAGONISThttps://conductscience.org/library/genes/1145
CHRNGMuscle-type nicotinic acetylcholine receptorMuscle-type nicotinic acetylcholine receptor agonistAGONISThttps://conductscience.org/library/genes/1146

Source ChEMBL

Diseases0

The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

None in this release.

Trials0

Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.

None in this release.

Comparisons in its trials0

Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.

None in this release.

Papers from its trials0

The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

None in this release.

Tests in its trials0

The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.

None in this release.

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
ClinicalTrials.gov
2026-11-05
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
Papers the trials list, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
Tests named in the trials, as ScienceGraph matched them
2026-11-12
ConductCognition

Sources 7

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ConductCognition's list of its testsOur own data
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this drug from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/drugs/v1/CHEMBL983

GET https://conductscience.org/api/drugs/v1/CHEMBL983/targets